I've been thinking calmly, coldly. The puts sold at $1.5 March have already been closed and the Calls purchased for the monthly expiration have been sold.
And I agree 100% with you. As ALWAYS, he demonstrates exceptional reasoning and intelligence.
The offer to give Denner the BOD of the company by buying 26M shares is not clear to me as to its purpose. It is too vague an offer for shareholders with current information. what does it offer? that contribute? what is it aiming for?
The only thing that I consider beneficial, apart from the SP, is that both parties are going to be forced to be clearer. To have better communication and treatment with the shareholder.
I want to wait for MItigate, the first round of reimbursements and see what peak sales leads to.
I want to remember that a multiple for a pharma (which still has r&d lines) is x5 its revenues. Even taking a VERY depressed amount already for the US generics of $367M (net), it appears that the $5 is giving away all the sales abroad. A dream (and who knows if the objective) of a BP.
...a good company does not sell itself, it can be bought. You GIA 100% until you don't... 100% OK.
Bullish
Market Data 
Markets 
AI
